Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe study page now returns a 403 Forbidden error, replacing the usual study record content with an access-denied screen while preserving site chrome like the header and footer.SummaryDifference21%

- Check49 days agoChange DetectedRevision tag at the bottom updates from v3.6.5 to v3.6.6. This signals a platform version update rather than a change to study content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe previously unavailable study page now loads the full study record for NCT03666325, including the Study Details and related sections. It also adds glossary terms and metadata to support indexing and navigation.SummaryDifference69%

- Check70 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a minor administrative update rather than substantive changes to study details.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.